Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate NVC-422 for Urinary Catheter Blockage and Encrustation

ClinicalTrials.gov ID: NCT01243125

Public ClinicalTrials.gov record NCT01243125. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-blind, Crossover Design, Pilot Study to Evaluate the Effect of NVC-422 Catheter Irrigation on Urinary Catheter Patency

Study identification

NCT ID
NCT01243125
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NovaBay Pharmaceuticals, Inc.
Industry
Enrollment
67 participants

Conditions and interventions

Interventions

  • NVC-422, 0.2% Drug
  • Sterile normal saline, 0.9% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2010
Primary completion
Jun 30, 2013
Completion
Jul 31, 2013
Last update posted
Aug 6, 2014

2010 – 2013

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Los Amigos Research and Education Institute (LAREI) Downey California 90242
Specialists in Urology Naples Florida 34102
Kessler Institute for Rehabilitation West Orange New Jersey 07052
Carolinas Medical Center Charlotte North Carolina 28203
Thomas Jefferson University Philadelphia Pennsylvania 19107
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
McGuire Veterans Affairs Medical Center Richmond Virginia 23249
Integrity Medical Research Mountlake Terrace Washington 98043

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01243125, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2014 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01243125 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →